Regeneron's Eylea Tops Roche Drugs in Study That May Boost Sales

... U.S. sales of Eylea surged 23 percent in 2014 to $1.74 billion from a year earlier, Regeneron said this month. The Tarrytown, New York-based company forecasts the sales will grow 25 percent to 30 percent this year. Bayer AG sells the medicine ...

http://ift.tt/19yZVfP